Similarly, Jun et al. demonstrated that STK4 overexpression suppressed proliferation and migration of breast cancer cells, whereas the application of an STK4 inhibitor reversed these effects and inhibited the Hippo pathway [26]. Here, STK4 is linked to breast carcinoma.